Epirubicin as adjuvant therapy for breast cancer.
Suh
C
C
Philadelphia College of Pharmacy, Philadelphia, Pennsylvania, USA.
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin